|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 3.370 USD | +1.81% |
|
-5.07% | +109.32% |
| 10-15 | MacroGenics Says First Patient Dosed in Phase 1 Study of MGC030 for Advanced Solid Tumors | MT |
| 08-17 | B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating | MT |
| Market Cap | 215M 192M 178M 162M 305M 20.33B 310M 2.14B 837M 10.61B 806M 789M 33.95B | P/E 2026 * |
-2.16x | P/E 2027 * | -2.05x |
|---|---|---|---|---|---|
| Enterprise Value | 215M 192M 178M 162M 305M 20.33B 310M 2.14B 837M 10.61B 806M 789M 33.95B | EV / Sales 2026 * |
1.98x | EV / Sales 2027 * | 2.37x |
| Free-Float |
96.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MGNX | Delayed | |
CBOE
| MGNX | Real-time | |
|
Deutsche Boerse AG
| M55 | Delayed | |
|
Börse Stuttgart
| M55 | Delayed | |
|
Tradegate
| M55 | Real-time | |
|
Boerse Muenchen
| M55 | Real-time | |
|
Berne S.E.
| M55 | End-of-day quote |
Last Transcript: MacroGenics, Inc.
| 1 day | +1.81% | ||
| 1 week | -5.07% | ||
| Current month | -12.69% | ||
| 1 month | -16.58% | ||
| 3 months | -21.99% | ||
| 6 months | -4.26% | ||
| Current year | +109.32% |
| 1 week | 3.19 |  | 3.76 |
| 1 month | 3.19 | | 4.2 |
| Current year | 1.58 | | 5.08 |
| 1 year | 1.29 | | 5.08 |
| 3 years | 0.99 | | 21.88 |
| 5 years | 0.99 | | 22.68 |
| 10 years | 0.99 | | 36.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Risser
CEO | Chief Executive Officer | 53 | 2025-08-12 |
James Karrels
DFI | Director of Finance/CFO | 59 | 2008-04-30 |
Frank Perabo
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Koenig
BRD | Director/Board Member | 73 | 2001-08-31 |
Eric Risser
BRD | Director/Board Member | 53 | 2025-08-12 |
Edward Hurwitz
BRD | Director/Board Member | 62 | 2004-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/6/26 | Exercice | Chief Technology Officer | 16,000 | 0.0251% | ||
| 8/19/26 | Sell | General Counsel | -31,105 | 0.0489% | ||
| 8/17/26 | Exercice | Chief Technology Officer | 80,000 | 0.1259% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | -5.07% | +99.41% | -33.53% | 211M | |
| +0.21% | -7.67% | +61.07% | +71.32% | 68.92B | |
| +1.66% | -9.54% | +10.39% | +60.04% | 51.9B | |
| +3.14% | +4.61% | +15.36% | +44.42% | 48.73B | |
| +3.45% | +4.70% | +33.44% | +35.96% | 43.13B | |
| -2.20% | +0.61% | +281.88% | +532.76% | 41.48B | |
| +6.43% | +6.84% | +18.32% | +109.23% | 39.96B | |
| +1.28% | -0.76% | +12.67% | +45.10% | 30.6B | |
| -2.21% | -14.22% | +40.33% | -0.94% | 26.01B | |
| +1.74% | -2.02% | -13.55% | -12.92% | 22.27B | |
| Average | +1.53% | -4.18% | +55.93% | +85.14% | 37.32B | |
| Weighted average by Cap. | +1.58% | -3.49% | +54.98% | +105.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108M 96.58M 89.76M 81.65M 154M 10.25B 156M 1.08B 422M 5.35B 406M 397M 17.11B | 90.61M 80.88M 75.17M 68.37M 129M 8.58B 131M 903M 353M 4.48B 340M 333M 14.33B |
| Net income | -88.7M -79.17M -73.59M -66.93M -126M -8.4B -128M -884M -346M -4.38B -333M -326M -14.03B | -138M -123M -115M -104M -196M -13.08B -200M -1.38B -538M -6.82B -518M -507M -21.84B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | US$3.370 | +1.81% | 578,082 |
| 26-10-14 | US$3.310 | -3.22% | 906,754 |
| 26-10-13 | US$3.420 | -8.06% | 559,140 |
| 26-10-12 | US$3.720 | -0.53% | 284,717 |
| 26-10-09 | US$3.740 | +5.35% | 418,442 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MGNX Stock
Select your edition
All financial news and data tailored to specific country editions
